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Background: Recent studies revealed that autophagy is up-regulated in obese individuals, as evidenced by
increased expression of autophagy related genes. As argued elsewhere, it is possible that initially insulin resistance
functions as an adaptive mechanism to increase autophagy in order to protect cells against death. We have shown
that Wistar Ottawa Karlsburg W (RT1u) rats (WOKW) develop a metabolic syndrome with insulin resistance in
adipose tissue, closely resembling the human disease. Therefore, the aim of this study was to characterize the
autophagy phenotype in WOKW rats to clarify the interrelation between insulin resistance and autophagy in
adipose tissue.
Methods: Subcutaneous and epidydimal adipose tissue samples of 5-months-old WOKW and healthy LEW.1 W
male rats were investigated and protein levels (Western blot and immunhistochemistry) of key autophagy genes,
including Atg5, Atg7, LC3-II/LC3-I and apoptosis marker cleaved caspase-3 were analyzed.
Results: WOKW rats displayed a significant increase of autophagy related proteins (Atg5, Atg7) in adipose tissue
compared with LEW.1 W. This increase was predominantly found in epididymal adipose tissue. Furthermore, the
LC3-II/LC3-I ratio as a marker of autophagosomes was significantly up-regulated in subcutaneous adipose tissue of
WOKW rats. Cleaved caspase-3 was just slightly detectable in visceral adipose tissue and not detected in
subcutaneous fat.
Conclusion: Insulin resistance in adipose tissue of obese WOKW rats is associated with up-regulation of differing
autophagy markers in visceral and subcutaneous fat depots. This fact not only qualifies the WOKW rat for further detailed
analysis of genetic determinants of metabolic syndrome but also highlights its suitability for autophagy research.
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Autophagy, or cellular self-digestion, is a catabolic process
which targets cell constituents (damaged organelles, un-
folded or misfolded proteins, intracellular pathogens) to
lysosomes for degradation [1,2]. Under basal conditions,
autophagy is involved in the degradation of long-lived
proteins whereas the ubiquitinproteasome pathway, a* Correspondence: Nora.Kloeting@medizin.uni-leipzig.de
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reproduction in any medium, provided the ordifferent catabolic process, is responsible for the deg-
radation of short-lived proteins [3,4]. The formation
of the phagophore and the autophagosomes requires
18 distinct Atg proteins (AuTophaGyrelated) initially
identified in yeast [5]. The process of autophagosome
formation involves initiation, nucleation and elongation/
enclosure [6]. The initiation step is controlled by the
ULK1–Atg13–FIP200 complex and the nucleation step
requires the Beclin-1–class III phosphatidylinositol 3-
kinase (PI3K) complex. The two conjugation systems
are divided in the elongation/enclosure step. The first is
the conjugation of Atg12-Atg5 mediated by two ligases
Atg7 and Atg10 and the second involves cleavage ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Atg8) by Atg4 releasing the soluble form LC3-I, which
is then conjugated to phosphatidylethanolamine (PE)
via participation of Atg7 and Atg3. This lipid conjuga-
tion forms the autophagic double membrane-associated
LC3-II protein allowing the closure of autophagic vacuole
[6]. LC3-II is used as a marker of autophagosomes [7].
The main inhibitor of autophagy is the serine/threonine
kinase mammalian target of rapamycin (mTOR), a com-
ponent of the mTORC1 complex [6].
As a survival mechanism, dysregulated autophagy has
been linked to many human pathophysiologies, such as
cancer, myopathies, neurodegeneration, heart and liver
diseases [8]. Interestingly, recent studies revealed that
autophagy is up-regulated in obese individuals, as evidenced
by increased expression of autophagy gene ATG5, LC3A,
and LC3B as well as elevated autophagic flux in omental
and subcutaneous adipose tissue [9]. Moreover, Codogno
and Meijer argued that initially obesity-induced insulin
resistance functions as an adaptive mechanism to in-
crease autophagy in order to protect cells against death
[10]. They further discussed that defective autophagy
may also underlie impaired insulin sensitivity in obesity
and that up-regulating autophagy can combat insulin
resistance [10].
Wistar Ottawa Karlsburg W (RT1u) rats (WOKW) de-
velop a complete metabolic syndrome with hypertension,
impaired glucose tolerance, hyperinsulinaemia, dyslipidemia
as well as insulin resistance in adipose tissue, closely resem-
bling the human disease [11-16]. Crossing studies con-
firmed that the metabolic syndrome of the WOKW rat is
under polygenic control and occurs in a gender-dependent
manner [16].
This relationship between increased autophagy and
obesity poses the question on a possible role of autophagy
in the state of obesity-induced insulin resistance in the
adipose tissue of WOKW rats. The aim of this study was
to characterize the autophagy phenotype of adipose tissue
in WOKW rats and clarify if there is a link between insu-
lin resistance and autophagy.
Material and methods
Animals
In 2011, breeding pairs of LEW.1 W (F105 + 2) and
WOKW (F102 + 2) rats from the Laboratory of Animal
Science, University of Greifswald, were obtained and
bred in our own animal facility under standardized
environmental conditions. Nine male rats of both strains
were used for these experiments. Animals were kept
in groups of four in Macrolon cages (Size 3, Ehret,
Emmendingen, Germany) under strict hygienic condi-
tions. They had free access to food and water and were
maintained at a 12-h light and dark cycle (5 AM/5 PM).
All experiments were conform to the Guide for the Careand Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85–23,
revised 1996) and were approved by the local authorities
of the state of Saxony, Germany as recommended by the
responsible local animal ethics review board (T58/12).
Phenotypic characterization
Two weeks before killing, all phenotypic characterizations
were carried out. Briefly, blood samples were obtained
from animals by puncturing the ophthalmic venous plexus
after 12 hours of fasting for determination of blood glu-
cose, serum triglycerides, total cholesterol, and serum
insulin. Blood glucose was determined using a glucose
analyser (Freestyle Mini, Abbott, Wiesbaden, Germany).
Serum triglycerides and total cholesterol were analysed
using an automatic analyzer (Roche Cobas Mira Plus,
Roche, Switzerland). Serum insulin was determined using
enzyme immunoassay kit (Rat Insulin ELISA, Mercodida
AB, Uppsala, Sweden). For calculating the body mass
index (BMI), the body length of animals was measured.
At the end of observation period left and right inguinal
adipose tissue pads were removed and weighed. The
sum of fat pads to body weight multiplied by 100 gave
the adiposity index.
Western blot
Animals were sacrificed and dorsal subcutaneous fat pads
and epididymal fat pads were removed. Tissues were lysed
by ultrasonication in 60 mMTris-HCl, pH 6.8, containing
2% sodium dodecyl sulfate (SDS) and 10% sucrose. Tissue
lysates were diluted 1:1 in sample buffer (250 mMTris-
HCl, pH 6.8, containing 4% SDS, 10% glycerol, and 2%
b-mercaptoethanol) and denatured at 95°C for 5 min.
Protein concentration was assessed with the BCA pro-
tein assay (Pierbo Science, Bonn, Germany). Proteins
(30 μg per lane) were separated by electrophoresis on
12.5% or 15% SDS-polyacrylamide gels and transferred
to nitrocellulose membranes by electroblotting. Nonspecific
binding sites were blocked with 5% dry milk for 45 min.
The blots were incubated with different antibodies at 4°C
overnight: mouse anti-LC3 (1:500; clone 2G6; Nanotools,
Munich, Germany), polyclonal rabbit anti-cleaved caspase-
3, Atg5 (D1G9) and Atg7 (all 1:1 000; Cell Signaling Tech-
nology, Danvers, USA). Proteins were detected by incubat-
ing with HRP conjugated secondary antibodies (1:4 000
dilution; Dianova) at RT for 2 h and chemiluminescence kit
(Amersham, Pharmacia, Freiburg, Germany). Integrated
optical densities of the immunoreactive protein bands were
measured with Gel Analyzer software (Media Cyberneties,
Silver Spring, MD). Equal protein loading was verified using
mouse anti-D-glyceraldehyde-3-phosphate dehydrogenase
antibody (GAPDH, Research Diagnostics, Flanders, The
Netherlands; 1:3 000). The extract of Jurkat cells with cyto-
chrome c-induced apoptosis (Cell Signaling Technology)
Table 1 Phenotype of LEW.1 W and WOKW rats at an age of 5 months (means ± SD)
Traits LEW.1 W (n = 9) p-value WOKW (n = 9)
Body weight (g) 486 ± 15 < 0.001 712 ± 21
BMI (kg/cm2) 0.68 ± 0.15 0.017 0.85 ± 0.12
Blood glucose (mmol/l) 5.8 ± 0.5 NS 6.5 ± 0.9
HbA1c (%) 3.70 ± 0.11 NS 3.72 ± 0.12
Serum insulin concentration (ng/ml) 2.1 ± 0.8 <0.001 10.1 ± 3.1
Triglycerides (mmol/l) 1.5 ± 0.5 <0.001 3.9 ± 0.5
Total cholesterol (mmol/l) 3.2 ±0.6 NS 2.8 ± 0.4
Adiposity index 1.1 ± 0.6 <0.001 3.5 ±0.6
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caspase-3.
Immunofluorescence staining for Atg5, Atg7, LC3 and
cleaved caspase-3
The subcutaneous and epididymal adipose tissues were
fixed in buffered 10% Zinc-formalin. The 20-μm-thick
frozen sections from the epididymal and subcutaneous
fat padswere mounted on gelatinized glass slides. After
buffer rinse, sections were incubated with mouse anti-
LC3 (1:250; clone 2G6; Nanotools,), Atg5 (D1G9), Atg7
(all 1:500; Cell Signaling Technology) and polyclonal rabbit
anti-cleaved caspase-3 (1:500) at 4°C overnight. After
buffer rinse, FITC-conjugated goat anti-rabbit IgG was
diluted 1:2000, and sections were incubated at room
temperature for another 2 h. Sections were mounted with
DakoGlycergel (DakoCytomation) containing 10 μg/mlFigure 1 Expression of autophagy markers Atg5 and Atg7 in visceral
Western blots and corresponding densitometrical analyses (Figure 1A, B) o
compared to the LEW.1 W control animals. The significant increased expres
animals. Data from n = 6 are presented as mean ± SEM * p ≤ 0.05, ** p ≤
together with the Newman-Keuls test. GAPDH was used as loading controlDAPI (Serva, Heidelberg, Germany) for nuclear staining
and 25 μg/ml DABCO (Sigma) to prevent photobleaching.
By replacement of the primary antisera with normal
mouse IgG, rabbit serum or PBS, respectively, no spe-
cific immunoreaction occurred.
Data analysis and statistics
Data are given as means ± SD unless stated otherwise. Data
sets were analyzed using a two-tailed unpaired t test, or dif-
ferences were assessed by one-way ANOVA using the
Statistical Package for Social Science, version 18.0 (SPSS,
Chicago, IL). P values <0.05 were considered significant.
Results
Phenotype of WOKW rats
The phenotypic characterization of the 5-month-old
WOKW and LEW.1 W rats studied is summarized inund subcutaneous fat of WOKW and LEW.1 W rats. Representative
f Atg5 and Atg7 in visceral and subcutaneous fat of WOKW rats
sion of Atg5 and Atg7 in visceral fat WOKW rats vs. LEW.1 W control
0.01, *** p ≤ 0.001, according to the one-way analysis of variance
. AU – arbitrary units.
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weight, BMI, fasting serum insulin as well as serum tri-
glyceride levels compared to the healthy LEW.1 W rats.
In contrast, HbA1c levels and blood glucose did not differ
between both strains. The adiposity index was significantly
increased in WOKW compared to LEW.1 W rats.
Enhanced autophagy in epidydimal adipose tissue of
WOKW rats
We first assessed the protein level of key autophagy re-
lated genes, Atg5 and Atg7, in visceral and subcutaneous
adipose tissue. As shown in Figure 1A and B, visceral
adipose tissue of WOKW rats displays a significant in-
crease in Atg5 and Atg7 protein expression compared to
healthy lean LEW.1 W. Atg5 was 2.3-fold increased andFigure 2 Detection of Atg5 and Atg7 expression in visceral fat of WO
higher immunofluorescence intensity of Atg5 and Atg7 was found in visce
(Figure 2A, B). Both proteins could only be detected in stromal cells of the
f). Scale bars: 15 μm (a - h); 30 μm (b’- h’).Atg7 displayed a 2-fold up-regulation. The expression
levels of Atg5 and Atg7 in subcutaneous adipose tissue
were comparable between both strains. Immunofluo-
rescence analysis confirmed the western blot results
(Figure 2A-B).
LC3-II/LC3-I ratio is up-regulated in SC fat tissue of
WOKW rats while cleaved caspase-3 is not altered
The analysis of the LC3-II/LC3-I ratio showed an up-
regulation of autophagosomes in subcutaneous adipose
tissue of WOKW rats (Figure 3A). Immunohistofluorescence
analysis confirmed the western blot results (Figure 3B).
Here, we detected a 2-fold increase in WOKW rats com-
pared to control animals. In addition, cleaved caspase-3 as
an apoptosis marker was just barely detectable in visceralKW and LEW.1 W rats by immunofluorescence. A significantly
ral fat of WOKW rats compared with LEW.1 W control animals
adipose tissue (arrow), rather in adipocytes directly (star; Figure 2B and
Figure 3 Expression of LC3-I and LC3-II proteins in visceral und subcutaneous fat WOKW and LEW.1 W rats. The over expression of the
LC3-II (membrane bound) protein and a significantly higher LC3-II / LC3-I ratio in subcutaneous fat of WOKW rats vs. LEW.1 W control animals.
Representative Western blots and corresponding densitometrical analyses (Figure 3A). The presence and location of the LC3 protein in
subcutaneous fat of WOKW and LEW.1 W rats is additionally shown by immunostaining. As shown for Atg5 and Atg7, adipocytes were
predominately negative for LC3 (star). Strong LC3 staining was found in stroma cells resembling macrophages (arrows; Figure 3B). Scale bars:
15 μm (a-d); 50 μm (b’-d’) (Figure 3B). Data from n = 6 are presented as mean ± SEM * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, according to the
one-way analysis of variance together with the Newman-Keuls test. GAPDH was used as loading control.
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3 detected in subcutaneous fat depot (Figure 4A-B).
Discussion
Recent studies revealed that autophagy is up-regulated in
human obesity [9] and it has been shown that autophagyis more pronounced in omental than in subcutaneous adi-
pose tissue [17]. In this study we demonstrate that insulin
resistant adipose tissue of WOKW rats display enhanced
autophagy with increased expression of autophagy genes.
Markers of autophagy were different in omental than in
subcutaneous adipose tissue. We found autophagy
Figure 4 Expression of apoptosis marker cleaved caspase-3. The cleaved caspase-3 expression is slightly detectable by Western blot and
immunofluorescence staining of visceral and subcutaneous fat of WOKW and LEW.1 W rats (Figure 4A, B). Bar represents 15 μm. The extract of
Jurkat cells with cytochrome c-induced apoptosis was used in Western blot as the positive control for occurrence of cleaved caspase-3.
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fat tissue of WOKW rates compared with LEW.1 W
rats. In accordance with results from studies in human
obesity, we found an increase of Atg5 and Atg7 expres-
sion in visceral adipose tissue of WOKW rats, suggesting
parallel alterations in the endocrine function of adipose
tissue both in human and in WOKW metabolic syndrome
[9]. Among the many autophagy-related genes, Atg7,
which encodes an ubiquitin-activating enzyme (E1)-like
enzyme, is pivotal for autophagosome formation [18] and
responsible for both Atg12-Atg5 conjugation and LC3
conversion. In livers of ob/ob mice it was shown that
Atg7 is dramatically down-regulated suggesting that re-
constitution of Atg7 expression would likely be an ef-
fective way to reestablish autophagy, at least in part, in
liver [19]. In addition, blocking autophagy using small
interfering RNA targeted to ATG7 in human Simpson-
Golabi-Behmel syndrome adipocytes resulted in up-
regulation of inflammatory marker [19]. These data in-
dicates that autophagy may function to dampen inflam-
matory gene expression and thereby limit excessive
inflammation in adipose tissue during obesity. Further
studies are needed, to determine to what extend inflam-
matory markers in WOKW rats are regulated by in-
creased autophagy in adipose tissues. Microtubule-
associated protein 1 light chain 3 (LC3), a homologue
of yeast Atg8 (Aut7/Apg8), localizes to autophagosomal
membranes after post-translational modifications. LC3-I is
cytosolic, whereas LC3-II is membrane bound [20]. The
C-terminal fragment of LC3 is cleaved immediately fol-
lowing synthesis to yield a cytosolic form called LC3-I.
A subpopulation of LC3-I is further converted to an
autophagosome-associating form, LC3-II [20,21]. Ac-
cordingly, the amount of LC3-II correlates well withthe number of autophagosomes [20]. This characteristic
conversion of LC3 can be used to monitor autophagic
activity [21]. Interestingly, autophagosomes measured
as LC3-II/LC3-I ratio were significantly up-regulated
only in subcutaneous adipose tissue of WOKW rats
compared with healthy LEW.1 W rats. This is consist-
ent with a human study from Jansen et al., showing that
levels of the autophagy marker LC3 were elevated in
subcutaneous adipose tissue of obese vs. lean human
subjects and positively correlated to both systemic insu-
lin resistance and morphological characteristics of adi-
pose tissue inflammation [22]. It has been shown by
Kadowaki and co-workers that LC3 ratio represents a
reliable index of autophagy formation and is much
more sensitive and proportional to changes in the pro-
teolytic rates than the ratio from the total homogenate
[23]. The macroautophagic degradation involves mul-
tiple steps and can occur by different signal transduction
pathways. The formation of the isolation membrane of the
autophagosome is the earliest event of macroautophagy,
which is dependent of the Atg5/Atg7 protein expression.
The interaction of Atg complex with LC3 protein and its
lipidation to membrane associated LC3-II form occurs in
the next steps [20,21]. The significantly up-regulated ex-
pression of Atg5/Atg7 proteins in visceral fat tissue of
WOKW rats can indicate on the induction of autophagy,
before the conversation of LC3 protein is detectable.
By contrast, in the subcutaneous adipose tissue, a
higher LC3-II/LC3-I ratio without any regulation of Atg
proteins expressions was detected. However, the pres-
ence of LC3 protein was only found in stroma cells
resembling macrophages. The Atg5/Atg7-independent
autophagic pathway with the LC3-positive and LC3-
negative autophagosomes was discovered in mouse
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phagocytosis (LAP) has been recently identified as a
phenomenon distinct from classical autophagy [25]. The
LC3-associated phagocytosis has been shown to be re-
quired for the efficient clearance of dead cells [26]. In the
light of these findings, the occurrence of LC3-associated
phagocytosis in subcutaneous adipose tissue of WOKW
rats cannot be excluded and may be associated with the
degradation of phagocytosed cellular corpses.
Interestingly, we found no differences in the amount of
cleaved caspase-3 between WOKW and LEW.1 W rats.
As an apoptosis marker, cleaved caspase-3 was barely
observed in visceral adipose tissue and not detected in
subcutaneous fat depot. In contrast, Alkhouri and co-
workers showed that both mitochondrial- and death
receptor-mediated caspase activation and adipocyte apop-
tosis were increased in the adipose tissue of obese humans
and diet-induced obese mice [27]. Based on the obviously
low levels of cleaved caspase-3 in adipose tissues of
WOKW rats, it could be argued that up-regulation of
autophagy protects from capase-3-mediated apoptosis.Conclusion
Polygenetically inherited metabolic syndrome of WOKW
rats is associated with enhanced autophagy in insulin
resistant adipose tissue. Furthermore, the increasing
autophagic activity seems to protect from caspase-3 me-
diated apoptosis. These findings further implicate that the
WOKW rat is a useful model for the human endocrine
status in obesity, the metabolic syndrome and also high-
lights its suitability for autophagy research.
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